Extranodal Lymphoma Originating from Mucosa-associated Lymphoid Tissue of the Nasopharynx

Acta Oto-Laryngologica

Volumn 123, Issue 9, 2003, Pages 1098-1101

  Prades, Eduardo ^a   Alobid, Isam ^a   Alós, Llucia ^a   Guilemany, Jose Maria ^a   Bernal Sprekelsen, Manuel ^a   Mullol, Joaquim ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Chemotherapy; Lymphoma; Mucosa associated lymphoid tissue; Nasopharynx

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; METHOTREXATE; PREDNISONE; VINCRISTINE;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; CONTRAST ENHANCEMENT; EPISTAXIS; EXTRANODAL LYMPHOMA; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MASTICATORY MUSCLE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NASOPHARYNX; NONHODGKIN LYMPHOMA; NOSE MUCOSA; NOSE OBSTRUCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; STOMACH MUCOSA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY, FINE-NEEDLE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ENDOSCOPY; HUMANS; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; MAGNETIC RESONANCE IMAGING; MALE; METHOTREXATE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PREDNISONE; PTERYGOID MUSCLES; TOMOGRAPHY, X-RAY COMPUTED; VINCRISTINE;

EID: 0346880131     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480310014868     Document Type: Article

References (21)

1. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002; 100: 2292-302.
2. Valdez R, Finn WG, Ross CW, Singleton TP, Tworek JA, Schnitzer B. Waldenström macroglobulinemia caused by extranodal marginal zone B-cell lymphoma: a report of six cases. Am J Clin Pathol 2001; 116: 683-90.
3. Tsang RW, Gospodarowicz MK, Pintilie M, et al. Stage I and II MALT lymphoma: results of treatment with radiotherapy. Int J Radiat Oncol Biol Phys 2001; 50: 1258-64.
4. Cavalli F, Isaacson PG, Gascoyne RD, Zucca E. MALT lymphomas. Hematology (Am Soc Hematol Educ Program) 2001; 241-258.
5. Ferrer A, Lopez-Guillermo A, Montserrat E, et al. Non-gastric mucosa-associated lymphoid tissue (MALT) lymphomas: analysis of 14 patients. Med Clin (Barc) 1999; 112: 577-80.
6. Sutcliffe N, Smith C, Speight PM, Isenberg DA. Mucosa-associated lymphoid tissue lymphomas in two patients with rheumatoid arthritis on second-line agents, and secondary Sjögren's syndrome. Rheumatology 2000; 39: 185-8.
7. Yokose T, Kodama T, Matsuno Y, Shimosato Y, Nishimura M, Mukai K. Low-grade B cell lymphoma of mucosa-associated lymphoid tissue in the thymus of a patient with rheumatoid arthritis. Pathol Int 1998; 48: 74-81.
8. Au WY, Gascoyne RD, Le N, et al. Incidence of second neoplasms in patients with MALT lymphoma: no increase in risk above the background population. Ann Oncol 2003; 10: 317-21.
9. Zucca E, Roggero E, Maggi-Solca N, et al. Prevalence of Helicobacter pylori and hepatitis C virus infections among non-Hodgkin's lymphoma patients in Southern Switzerland. Haematologica 2000; 85: 147-53.
10. Royer B, Cazals-Hatem D, Sibilia J, et al. Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood 1997; 90: 766-75.
11. McClain KL. Epstein-Barr virus and HIV-AIDS-associated diseases. Biomed Pharmacother 2001; 55: 348-52.
12. Chan WY, Chan EK, Chow JH. Epstein-Barr virus-associated gastric lymphomas are distinct from mucosa-associated lymphoid tissue-type lymphomas: genetic abnormalities of p53 gene. Diagn Mol Pathol 2001; 10: 153-60.
13. Levine AM, Sadeghi S, Espina B, Tulpule A, Nathwani B. Characteristics of indolent non-Hodgkin lymphoma in patients with type 1 human immunodeficiency virus infection. Cancer 2002; 94: 1500-6.
14. Zucca E, Bertoni F, Roggero E, Cavalli F. The gastric marginal zone B-cell lymphoma of MALT type. Blood 2000; 96: 410-9.
15. Hussell T, Isaacson PG, Crabtree JE, Spencer J. Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue. J Pathol 1996; 178: 122-7.
16. Krugmann J, Dirnhofer S, Gschwendtner A, et al. Primary gastrointestinal B-cell lymphoma. A clinicopathological and immunohistochemical study of 61 cases with an evaluation of prognostic parameters. Pathol Res Pract 2001; 197: 385-93.
17. Levy M, Copie-Bergman C, Traulle C, et al. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome. Am J Gastroenterol 2002; 97: 292-7.
18. Raderer M, Traub T, Formanek M, et al. Somatostatin-receptor scintigraphy for staging and follow-up of patients with extraintestinal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT)-type. Br J Cancer 2001; 85: 1462-6.
19. Penz MZ, Fiebiger WC, Valencak JB, et al. Beta-2-microglobulin levels in patients with extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type: a retrospective analysis. Anticancer Res 2001; 21: 3049-52.
20. Ferry JA, Yang WI, Zukerberg LR, Wotherspoon AC, Arnold A, Harris NL. CD5+ extranodal marginal zone B-cell (MALT) lymphoma. A low grade neoplasm with a propensity for bone marrow involvement and relapse. Am J Clin Pathol 1996; 105: 31-7.
21. Wensel C, Fiebiger W, Dieckmann K, Formanek M, Choot A, Raderer M. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of the head and neck area. Cancer 2003; 97: 2236-41.